Single Annual EMA Fee Proposal Holds Most Promise For Pharma
Annual Fee Concept Can Simplify Many Of The Current Complexities
Europe’s research-based industry association picks its preferred way forward for simplifying the European Medicines Agency’s fee system.
You may also be interested in...
The European Medicines Agency has identified key areas where stakeholders want to see it deliver a real change over the next five years.
Following a report that identified several shortcomings of the European Medicines Agency fee system, the European Commission has suggested various options to make it sustainable and future-proof.
The European pharmaceutical industry federation, EFPIA, says its member companies are not looking for shortcuts to develop and validate digital biomarkers, but want help from regulators to create the right evidence.